PRIMECAP MANAGEMENT CO 13D and 13G filings for Calithera Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 4:02 pm Purchase |
2022-12-31 | 13G | Calithera Biosciences, Inc. CALA |
PRIMECAP MANAGEMENT CO | 401,080 8.240% |
201,117 (+100.58%) |
Filing |
| 2023-02-09 4:01 pm Sale |
2023-01-31 | 13G | Calithera Biosciences, Inc. CALA |
PRIMECAP MANAGEMENT CO | 199,963 4.110% |
-206,317 (-50.78%) |
Filing |
| 2022-12-08 11:49 am Purchase |
2022-11-30 | 13G | Calithera Biosciences, Inc. CALA |
PRIMECAP MANAGEMENT CO | 406,280 8.350% |
406,280 (New Position) |
Filing |